Palisade Bio PALI
NASDAQ PALI
$1.41 -0.04 (-2.76%)
As of: Sep 30, 2026 · 12:52 PM EDT

Palisade Bio, Inc. (PALI) EBITDA Margin (2011 - 2026)

Updated

Palisade Bio (PALI) posted EBITDA Margin of -2339.60% for Q2 2026.

Analysis

Palisade Bio, Inc. (PALI) EBITDA Margin (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Palisade Bio was -7069.60%; for FY2023, it was -5226.40%.

  • Annual EBITDA Margin shows a five-year change of -2121.15 percentage points (FY2018 to FY2023).
  • In prior years, Palisade Bio's EBITDA Margin was -68742.60% in FY2020 (-13605.31 pp) and -55137.29% in FY2019 (-52032.04 pp).
  • The Q2 2026 figure stands as the highest quarterly EBITDA Margin since Q1 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,339.60%
Mar 31, 2023 -1,011.20%
Dec 31, 2020 -129,760.00%
Sep 30, 2020 -72,600.00%
Jun 30, 2020 -74,763.12%
Mar 31, 2020 -32,581.16%
Dec 31, 2019 -84,097.96%
Sep 30, 2019 -83,503.64%
Jun 30, 2019 -23,828.87%
Mar 31, 2019 -96,669.76%
Dec 31, 2018 -71,179.04%
Sep 30, 2018 -81,460.88%
Jun 30, 2018 -782.59%
Mar 31, 2018 -91,264.84%
Dec 31, 2017 -876.58%
Sep 30, 2017 -101,394.80%
Jun 30, 2017 -165,994.00%
Mar 31, 2017 -164,792.08%
Dec 31, 2016 -63,909.48%
Sep 30, 2016 -192,777.16%
API Access

Palisade Bio, Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PALI&period=max&api_key=YOUR_API_KEY